These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 617265)

  • 1. Therapeutic trials in muscular dystrophy: II. Ethylene and its derivatives.
    Enomoto A; Bradley WG
    Ann Neurol; 1977 Oct; 2(4):267-70. PubMed ID: 617265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strength and endurance in the therapeutic evaluation of prednisolone-treated MDX mice.
    Hudecki MS; Pollina CM; Granchelli JA; Daly MK; Byrnes T; Wang JC; Hsiao JC
    Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):45-60. PubMed ID: 8434132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study.
    Grounds MD; McGeachie JK
    Muscle Nerve; 1992 May; 15(5):580-6. PubMed ID: 1584249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of copper/zinc superoxide dismutase: a novel cause of murine muscular dystrophy.
    Rando TA; Crowley RS; Carlson EJ; Epstein CJ; Mohapatra PK
    Ann Neurol; 1998 Sep; 44(3):381-6. PubMed ID: 9749606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate.
    Marques MJ; Luz MA; Minatel E; Neto HS
    Neurosci Lett; 2005 Jul; 382(3):342-5. PubMed ID: 15925116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts from mdx and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts.
    Chen G; Bressler BH; Quinn LS
    Cell Biol Int; 1994 Apr; 18(4):229-35. PubMed ID: 8044140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse.
    Pastoret C; Sebille A
    Muscle Nerve; 1995 Oct; 18(10):1147-54. PubMed ID: 7659109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
    Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
    Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles.
    Weller B; Massa R; Karpati G; Carpenter S
    Muscle Nerve; 1991 Aug; 14(8):771-4. PubMed ID: 1891001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
    Bartoli M; Poupiot J; Goyenvalle A; Perez N; Garcia L; Danos O; Richard I
    Gene Ther; 2006 Jan; 13(1):20-8. PubMed ID: 16107863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Muscle protein turnover in the dystrophic mice].
    Mizobuchi M
    Rinsho Shinkeigaku; 1983 May; 23(5):436-44. PubMed ID: 6883888
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors inducing mast cell accumulation in skeletal muscle.
    Lefaucheur JP; Gjata B; Sebille A
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):248-55. PubMed ID: 8804027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouse.
    Anderson JE; Kakulas BA; Jacobsen PF; Johnsen RD; Kornegay JN; Grounds MD
    Growth Factors; 1993; 9(2):107-21. PubMed ID: 8217214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glycerophosphorylcholine synthesis in murine muscular dystrophy.
    Infante JP
    Med Biol; 1985; 63(2):81-7. PubMed ID: 4068770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles.
    Kherif S; Lafuma C; Dehaupas M; Lachkar S; Fournier JG; Verdière-Sahuqué M; Fardeau M; Alameddine HS
    Dev Biol; 1999 Jan; 205(1):158-70. PubMed ID: 9882504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
    McIntosh LM; Pernitsky AN; Anderson JE
    Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.